Sino Biological,Inc. (SHE:301047)
China · Delayed Price · Currency is CNY 73.10
-0.73 (-0.99%)
At close: May 12, 2026
Sino Biological,Inc. Revenue
Sino Biological,Inc. had revenue of 183.42M CNY in the quarter ending March 31, 2026, with 18.11% growth. This brings the company's revenue in the last twelve months to 727.69M, up 18.01% year-over-year. In the year 2025, Sino Biological,Inc. had annual revenue of 699.56M with 14.00% growth.
Revenue (ttm)
727.69M
Revenue Growth
+18.01%
P/S Ratio
12.34
Revenue / Employee
680.72K
Employees
1,069
Market Cap
8.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 699.56M | 85.89M | 14.00% |
| Dec 31, 2024 | 613.67M | -32.72M | -5.06% |
| Dec 31, 2023 | 646.39M | 71.79M | 12.49% |
| Jan 1, 2023 | 574.60M | -390.67M | -40.47% |
| Jan 1, 2022 | 965.27M | -631.02M | -39.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Youcare Pharmaceutical Group | 2.42B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.84B |
| Aurisco Pharmaceutical | 1.68B |
| Nanjing Vazyme Biotech | 1.41B |
| Jiangxi Fushine Pharmaceutical | 1.31B |
| Liaoning Chengda Biotechnology | 1.31B |
| Shanghai Medicilon | 1.26B |
| Bio-Thera Solutions | 980.25M |